跳至主要内容
临床试验/KCT0002363
KCT0002363招募中未知

Effects of anti-viral agent on survival and liver related mortality in patients with chronic hepatitis B virus: a systematic review study

Hanyang University Seoul Hospital0 个研究点目标入组 1,000 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
o Limit 至 o Limit(—)
性别
All

入选标准

  • 1. Inclusion criteria
  • 1) patients who were prescribed oral antiviral agents for a treatment of CHB during the study period
  • 2) CHB patients with episode of liver decompensation defined as the occurence of complications such as refractory ascites, variceal bleeding, encephalopathy, or hepatorenal syndrome.
  • 3) patients of any age of either sex

排除标准

  • 2. Exclusion criteria
  • 1) patients who were diagnosted with all cancer before a treatment of CHB

研究者

发起方
Hanyang University Seoul Hospital

相似试验